Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Gear Energy: Flexibility Will Further Improve Q2 Results

2018-07-17 seekingalpha
The only thing I am sure of about the next few weeks is that we should expect continued volatility, and a lot of it.
GENGF GXE

7
Enbridge's Line 3 Expansion Approval Offers A Nice Tailwind For Canadian Heavy Oil Producers

2018-06-29 seekingalpha
Minnesota PUC approved Enbridge's Line 3 expansion yesterday providing a bullish tailwind for Canadian heavy oil producers.
ENB CVE MEG CVE MEGEF GENGF GXE ENB

53
Raging River: Endure The Pain

2018-06-20 seekingalpha
Raging River agreed to merge with Baytex for a small premium. After today’s selloff, the market is saying both are better at it alone.
BTE RRENF GXE GENGF PTORF SPE RRX

67
Unknown, Profitable, Oil-Weighted Energy Producer At Deep Discount To NAV And Peers

2018-05-23 seekingalpha
Razor Energy is an oil-weighted energy producer that has increased its production significantly since 2017 while maintaining a strong balance sheet with leverage being well below 2 times.
BTE PGH CJ CRLFF CPG WCP YGR BNEFF VET SGY ZPTAF RRENF YGRAF RRX QTEYF GXOCF QEC TNEYF GENGF ATU CPG BNE RZREF GXO VET IPOOF GXE BTE SPGYF

4
The Positive Reflexive Feedback Loop Has Started For Energy Stocks

2018-05-21 seekingalpha
Energy sector performance relative to WTI has broken out of a downtrend that's been in place since the start of 2017.
CRC GENGF GXE

30
2018 Best Ideas Update - How Did We Do And Where They Are Headed

2018-05-11 seekingalpha
We give an update on our three best ideas of the year: California Resources, Gear Energy and Discovery Communications.
CRC DISCB DISCA GENGF GXE DISCK DISC

0
Gear Energy Ltd. Announces Results of Directors Vote

2018-05-09 globenewswire
CALGARY, Alberta, May 09, 2018 (GLOBE NEWSWIRE) -- Gear Energy Ltd. (“Gear”) (TSX:GXE) is pleased to announce that the nominees listed in the management proxy circular dated April 2, 2018 were elected as directors of Gear. The detailed results of the vote for the election of directors held at Gear's annual meeting of shareholders held today (the “Meeting”) are set out below.
GXE GENGF

4
Weekly Oil Markets Recap - Outperformance Comes From Conviction And Patience

2018-05-06 seekingalpha
Not only is oil regaining multi-year highs, the HFI Portfolio and energy stocks are moving higher as well. As we wrote in a daily this week titled, "Leaderboard Change: Energy Stocks Climbing To The Top." There has been a not so subtle shift in the market leaderboard in April, and energy stocks are now climbing to the top.
CRC GENGF GXE

11
Using The Power Of Incentives To Understanding Markets And Oil

2018-05-04 seekingalpha
"Never, ever, think about something else when you should be thinking about the power of incentives." ~ Charlie Munger.
CRC GENGF GXE BXE

22
Open Square Fund Q1 2018 Commentary (Part 2 Of 2)

2018-04-19 seekingalpha
The market is currently distracted by the narratives of technology to the exclusion of other sectors.
CRC CDEV WLL GXE GENGF

4
Weekly Oil Markets Recap - Energy Stocks Aren't So Hated Anymore

2018-04-15 seekingalpha
Energy stocks have managed to outperform the broader markets by 9.8% since the middle of March, the steepest and fastest outperformance since the oil downturn.
CRC GENGF GXE

6
Buy Canadian Heavy Oil Producers As The WCS-WTI Discount Narrows

2018-04-03 seekingalpha
Canadian heavy oil producer equities have diverged greatly from the recent improvement in Western Canadian Select prices or WCS. The discount between WCS and WTI continues to narrow allowing knowledgeable investors to take advantage of the complacency in Canada.
KMI.PRA KMI KMI.WS GENGF GXE KMR KMRFZ CVB

0
This Small-Cap Oil Producer Is Too Cheap To Ignore

2018-03-28 seekingalpha
Concerns over Canadian heavy oil are overblown as WCS spreads have already started to tighten and crude by rail shipments increasing.
GENGF GXE

0
BRIEF-Gear Energy Announces Operational Update And 2018 Revised Outlook

2018-03-21 reuters
* GEAR ENERGY LTD - SEES 2018 CAPITAL AND ABANDONMENT EXPENDITURES OF $50 MILLION Source text for Eikon: Further company coverage:
GXE GENGF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...